Recommended Topic Related To:

Ventolin Syrup

"The U.S. Food and Drug Administration will complete its phase-out of all inhaler medical products containing chlorofluorocarbons (CFCs) by Dec. 31, 2013. This effort is to comply with an international treaty to protect the ozone layer by phasing "...

Ventolin Syrup

Discontinued Warning IconPlease Note: This Brand Name drug is no longer available in the US.
(Generic versions may still be available.)

Side Effects
Interactions

SIDE EFFECTS

The adverse reactions to albuterol are similar in nature to those of other sympathomimetic agents. In clinical trials, the most frequent adverse reactions to VENTOLIN Syrup (albuterol sulfate syrup) in adults and older children were:

Percent Incidence of Adverse Reactions in Adults and Children (6-12 Years of Age)

Adverse Event

Percent Incidence

Central Nervous System

 

Tremor

10

Nervousness

9

Shakiness

9

Headache

4

Dizziness

3

Excitement

2

Hyperactivity

2

Sleeplessness

1

Disturbed sleep

<1

Irritable behavior

<1

Dilated pupils

<1

Weakness

1

Cardiovascular

 

Tachycardia

1

Palpitations

<1

Sweating

<1

Chest Pain

<1

Ear, Nose, and Throat

 

Epistaxis

1

Gastrointestinal

 

Increased appetite

3

Epigastric pain

<1

Stomachache

<1

Musculoskeletal

 

Muscle spasm

<1

Respiratory

 

Cough

<1

 

In clinical trials, the following adverse reactions to VENTOLIN Syrup (albuterol sulfate syrup) were noted more frequently in young children 2 to 6 years of age than in adults and older children:

Percent Incidence of Adverse Reactions Noted More Frequently in Children 2 to 6 Years of Age Than in Older Children and Adults

Adverse Event

Percent Incidence

Central Nervous System

 

Excitement

20

Nervousness

15

Hypokinesia

4

Sleeplessness

2

Emotional lability

1

Fatigue

1

Cardiovascular

 

Tachycardia

2

Pallor

1

Gastrointestinal

 

Gastrointestinal symptoms

2

Loss of appetite

1

Ophthalmologic

 

Conjunctivitis

1

Cases of urticaria, angioedema, rash, bronchospasm, oropharyngeal edema, and arrhythmias (including atrial fibrillation, supraventricular tachycardia, and extrasystoles) have been reported after the use of VENTOLIN Syrup (albuterol sulfate syrup) .

In addition, albuterol, like other sympathomimetic agents, can cause adverse reactions such as angina, central nervous system stimulation, drying or irritation of the oropharynx, hypertension, nausea, unusual taste, vertigo, and vomiting.

The reactions are generally transient in nature, and it is usually not necessary to discontinue treatment with VENTOLIN Syrup (albuterol sulfate syrup) . In selected cases, however, dosage may be reduced temporarily; after the reaction has subsided, dosage should be increased in small increments to the optimal dosage.

Read the Ventolin Syrup (albuterol sulfate syrup) Side Effects Center for a complete guide to possible side effects

DRUG INTERACTIONS

The concomitant use of VENTOLIN Syrup (albuterol sulfate syrup) and other oral sympathomimetic agents is not recommended since such combined use may lead to deleterious cardiovascular effects. This recommendation does not preclude the judicious use of an aerosol bronchodilator of the adrenergic stimulant type in patients receiving VENTOLIN Syrup (albuterol sulfate syrup) . Such concomitant use, however, should be individualized and not given on a routine basis. If regular coadministration is required, then alternative therapy should be considered.

Beta-Blockers

Beta-adrenergic receptor blocking agents not only block the pulmonary effect of beta-agonists, such as VENTOLIN Syrup (albuterol sulfate syrup) , but may produce severe bronchospasm in asthmatic patients. Therefore, patients with asthma should not normally be treated with beta-blockers. However, under certain circumstances, eg, as prophylaxis after myocardial infarction, there may be no acceptable alternatives to the use of beta-adrenergic blocking agents in patients with asthma. In this setting, cardioselective beta-blockers could be considered, although they should be administered with caution.

Diuretics

The ECG changes and/or hypokalemia that may result from the administration of nonpotassium-sparing diuretics (such as loop or thiazide diuretics) can be acutely worsened by beta-agonists, especially when the recommended dose of the beta-agonist is exceeded. Although the clinical significance of these effects is not known, caution is advised in the coadministration of beta-agonists with nonpotassium-sparing diuretics.

Digoxin

Mean decreases of 16% to 22% in serum digoxin levels were demonstrated after single dose intravenous and oral administration of albuterol, respectively, to normal volunteers who had received digoxin for 10 days. The clinical significance of these findings for patients with obstructive airway disease who are receiving albuterol and digoxin on a chronic basis is unclear. Nevertheless, it would be prudent to carefully evaluate the serum digoxin levels in patients who are currently receiving digoxin and albuterol.

Monoamine Oxidase Inhibitors or Tricyclic Antidepressants

Albuterol should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants, or within 2 weeks of discontinuation of such agents, because the action of albuterol on the vascular system may be potentiated.

Last reviewed on RxList: 12/17/2004
This monograph has been modified to include the generic and brand name in many instances.

Side Effects
Interactions
A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Allergies & Asthma

Improve treatments & prevent attacks.


NIH talks about Ebola on WebMD